Clinical reference Biomarker Directory
Back to directory

Complement C4

Established

C4 deficiency carries one of the strongest known genetic associations with lupus among complement defects.

Also known as C4 C4A C4B
In plain language

C4 is an early complement protein whose complete absence gives one of the highest known genetic risks for lupus — about three in four people who lack it will develop the disease.

Biomarker & context

C4 is an early classical complement pathway component activated by C1, working with C2 to form C3 convertase and propagate the complement cascade; it exists in two genetically variable forms (C4A and C4B).

What it indicates

C4 deficiency carries one of the strongest genetic associations with systemic lupus erythematosus among all complement deficiencies, with roughly 75% of complete C4-deficient individuals developing SLE, reflecting impaired clearance of immune complexes and apoptotic debris.

Diagnosis & clinical testing

Screened via CH50 with confirmatory specific C4 level testing; genetic copy-number variation in the C4A/C4B genes (rather than complete deficiency) is also studied as a more common, graded lupus risk factor in the general population.

Guiding treatment

Confirmed C4 deficiency warrants close monitoring for lupus development and genetic counseling; ongoing research into partial C4 gene copy-number variation may eventually refine risk assessment beyond simple deficient/non-deficient categorization.

Clinical significance

Note: this overlaps substantially with the C1q/C2/C3/C5-C9 complement group discussed together elsewhere; consider consolidating on a published site.

References
  1. StatPearls. (2023). Complement Deficiency — Treatment & Management.
  2. MD Searchlight. (2025). Complement Deficiency.